SciCombinator

Discover the most talked about and latest scientific content & concepts.

A novel approach to administration of peptides in women: Systemic absorption of a GnRH agonist via transvaginal ring delivery system

OPEN Journal of controlled release : official journal of the Controlled Release Society | 1 May 2016

AB Kimball, E Javorsky, ES Ron, W Crowley and R Langer
Abstract
trans-Epithelial delivery of medication across the vagina has proven successful for administration of small, lipophilic molecules such as sex steroids. However, little information is available regarding the vaginal delivery of larger and more polar molecules that currently require parenteral administration reflecting the bias that vaginal epithelium is a barrier to absorption of larger molecular weight (MW) molecules. Six healthy women underwent administration of 18 or 36mg of leuprolide, a GnRH agonist and a larger MW peptide, via a novel ethylene vinyl acetate (EVA) ring transvaginal drug delivery system (TVDS). Serum levels rose within 8h following insertion: low dose at 310pg/ml and high dose at 1220pg/ml, i.e. levels typically following parenteral injections of leuprolide. GnRHa biological activity was validated by secretion of gonadotropins and sex steroids. These results demonstrate that the non-keratinized vaginal epithelium permits a rapid absorption of a biologically active peptide and that there is significant potential for a novel TVDS to deliver peptides and possibly other macromolecules therapeutically.
Tweets*
5
Facebook likes*
1
Reddit*
0
News coverage*
72
Blogs*
0
SC clicks
0
Concepts
Pharmacology, Vagina, Human sexuality, Reproductive system, Peptide, Cervix, Molecule, Childbirth
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com